Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

2 structures for P26954

Entry ID Method Resolution Chain Position Source
4QQV X-ray 345 A A/B/C/D 23-438 PDB
AF-P26954-F1 Predicted AlphaFoldDB

90 variants for P26954

Variant ID(s) Position Change Description Diseaes Association Provenance
rs31526769 6 A>T No EVA
rs3389364530 8 T>K No EVA
rs578868725 18 A>T No EVA
rs234722002 28 E>A No EVA
rs3389386298 37 L>M No EVA
rs31524721 38 E>Q No EVA
rs3389372590 39 C>Y No EVA
rs586785979 45 N>S No EVA
rs583529437 46 R>H No EVA
rs3389364565 47 I>T No EVA
rs31524717 71 D>E No EVA
rs31527847 83 K>E No EVA
rs3389386338 87 S>A No EVA
rs3389361748 114 Y>* No EVA
rs108610797 139 P>L No EVA
rs259650908 142 D>N No EVA
rs240586100 143 I>V No EVA
rs221203346 144 H>N No EVA
rs262708373 144 H>R No EVA
rs237013238 148 S>A No EVA
rs222086975 157 S>N No EVA
rs3389323272 188 D>E No EVA
rs582799097 190 S>Y No EVA
rs31524357 201 L>F No EVA
rs31524355 213 A>V No EVA
rs229496016 222 A>P No EVA
rs229496016 222 A>T No EVA
rs3389364532 229 R>K No EVA
rs3413120386 238 H>Y No EVA
rs3389351834 244 G>R No EVA
rs3389374220 249 P>S No EVA
rs3389372639 266 W>* No EVA
rs3389365786 266 W>R No EVA
rs587434742 297 V>A No EVA
rs3389368638 299 E>D No EVA
rs1132585135 304 V>I No EVA
rs254237490 309 R>H No EVA
rs3389340253 347 P>L No EVA
rs262770025 348 I>T No EVA
rs31528191 351 Q>L No EVA
rs253775905 353 K>N No EVA
rs1133130567 361 H>Y No EVA
rs31528189 363 E>K No EVA
rs3406011966 377 V>L No EVA
rs224320780 398 N>H No EVA
rs3389372596 399 S>N No EVA
rs247315434 410 S>T No EVA
rs3389291008 411 Y>* No EVA
rs3389368668 413 A>T No EVA
rs230996725 434 Y>H No EVA
rs3389380462 437 T>K No EVA
rs1133836370 444 T>M No EVA
rs107799188 456 F>L No EVA
rs3389372593 505 F>I No EVA
rs583823629 529 E>A No EVA
rs237084340 535 N>D No EVA
rs580064555 536 V>L No EVA
rs585956124 548 R>Q No EVA
rs578536235 551 P>T No EVA
rs31524102 553 R>G No EVA
rs585409962 571 V>I No EVA
rs581666739 574 E>K No EVA
rs31524101 577 I>T No EVA
rs3389290995 607 L>P No EVA
rs579306555 609 G>D No EVA
rs3389364605 610 Q>H No EVA
rs585125366 614 P>S No EVA
rs581465571 618 G>R No EVA
rs108137268 619 S>N No EVA
rs3389291011 647 V>M No EVA
rs1131825274 683 E>D No EVA
rs3389372622 685 Q>* No EVA
rs584724439 692 M>T No EVA
rs31524095 692 M>V No EVA
rs31577888 703 G>D No EVA
rs3389340276 728 S>Y No EVA
rs3389361801 761 G>W No EVA
rs3389380419 771 S>T No EVA
rs581007220 775 A>T No EVA
rs239391925 777 T>K No EVA
rs3389364589 790 S>R No EVA
rs3389364569 848 E>D No EVA
rs583116599 850 L>P No EVA
rs3389370761 852 Q>H No EVA
rs3389340243 858 K>R No EVA
rs3389372582 867 A>V No EVA
rs3389365739 868 P>L No EVA
rs3389386274 869 A>S No EVA
rs580535245 878 Y>H No EVA
rs3389386281 879 Y>R No EVA

No associated diseases with P26954

5 regional properties for P26954

Type Name Position InterPro Accession
conserved_site Short hematopoietin receptor, family 1, conserved site 405 - 436 IPR003531
domain Fibronectin type III 137 - 244 IPR003961-1
domain Fibronectin type III 343 - 438 IPR003961-2
domain Growth hormone/erythropoietin receptor, ligand binding 247 - 336 IPR015152
domain Interferon/interleukin receptor domain 367 - 431 IPR015373

Functions

Description
EC Number
Subcellular Localization
  • Membrane; Single-pass type I membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
external side of plasma membrane The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
granulocyte macrophage colony-stimulating factor receptor complex The heterodimeric receptor for granulocyte macrophage colony-stimulating factor.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

1 GO annotations of molecular function

Name Definition
cytokine receptor activity Combining with a cytokine and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.

6 GO annotations of biological process

Name Definition
cytokine-mediated signaling pathway The series of molecular signals initiated by the binding of a cytokine to a receptor on the surface of a cell, and ending with the regulation of a downstream cellular process, e.g. transcription.
granulocyte-macrophage colony-stimulating factor signaling pathway The series of molecular signals initiated by the binding of the cytokine granulocyte macrophage colony-stimulating factor (GM-CSF) to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. GM-CSF binds to a heterodimer receptor (CSF2R) consisting of an alpha ligand-binding subunit, and a common beta subunit that is shared with other cytokine receptors.
immunoglobulin mediated immune response An immune response mediated by immunoglobulins, whether cell-bound or in solution.
positive regulation of leukocyte proliferation Any process that activates or increases the frequency, rate or extent of leukocyte proliferation.
protein phosphorylation The process of introducing a phosphate group on to a protein.
receptor signaling pathway via JAK-STAT Any process in which STAT proteins (Signal Transducers and Activators of Transcription) and JAK (Janus Activated Kinase) proteins convey a signal to trigger a change in the activity or state of a cell. The receptor signaling pathway via JAK-STAT begins with activation of a receptor and proceeeds through STAT protein activation by members of the JAK family of tyrosine kinases. STAT proteins dimerize and subsequently translocate to the nucleus. The pathway ends with regulation of target gene expression by STAT proteins.

4 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P26955 Csf2rb Cytokine receptor common subunit beta Mus musculus (Mouse) PR
P14753 Epor Erythropoietin receptor Mus musculus (Mouse) PR
Q08351 Mpl Thrombopoietin receptor Mus musculus (Mouse) PR
Q01114 Il9r Interleukin-9 receptor Mus musculus (Mouse) PR
10 20 30 40 50 60
MDQQMALTWG LCYMALVALC WGHEVTEEEE TVPLKTLECY NDYTNRIICS WADTEDAQGL
70 80 90 100 110 120
INMTLLYHQL DKIQSVSCEL SEKLMWSECP SSHRCVPRRC VIPYTRFSNG DNDYYSFQPD
130 140 150 160 170 180
RDLGIQLMVP LAQHVQPPPP KDIHISPSGD HFLLEWSVSL GDSQVSWLSS KDIEFEVAYK
190 200 210 220 230 240
RLQDSWEDAS SLHTSNFQVN LEPKLFLPNS IYAARVRTRL SAGSSLSGRP SRWSPEVHWD
250 260 270 280 290 300
SQPGDKAQPQ NLQCFFDGIQ SLHCSWEVWT QTTGSVSFGL FYRPSPAAPE EKCSPVVKEP
310 320 330 340 350 360
QASVYTRYRC SLPVPEPSAH SQYTVSVKHL EQGKFIMSYY HIQMEPPILN QTKNRDSYSL
370 380 390 400 410 420
HWETQKIPKY IDHTFQVQYK KKSESWKDSK TENLGRVNSM DLPQLEPDTS YCARVRVKPI
430 440 450 460 470 480
SDYDGIWSEW SNEYTWTTDW VMPTLWIVLI LVFLIFTLLL ALHFGRVYGY RTYRKWKEKI
490 500 510 520 530 540
PNPSKSLLFQ DGGKGLWPPG SMAAFATKNP ALQGPQSRLL AEQQGVSYEH LEDNNVSPLT
550 560 570 580 590 600
IEDPNIIRDP PSRPDTTPAA SSESTEQLPN VQVEGPIPSS RPRKQLPSFD FNGPYLGPPQ
610 620 630 640 650 660
SHSLPDLPGQ LGSPQVGGSL KPALPGSLEY MCLPPGGQVQ LVPLSQVMGQ GQAMDVQCGS
670 680 690 700 710 720
SLETTGSPSV EPKENPPVEL SVEKQEARDN PMTLPISSGG PEGSMMASDY VTPGDPVLTL
730 740 750 760 770 780
PTGPLSTSLG PSLGLPSAQS PSLCLKLPRV PSGSPALGPP GFEDYVELPP SVSQAATSPP
790 800 810 820 830 840
GHPAPPVASS PTVIPGEPRE EVGPASPHPE GLLVLQQVGD YCFLPGLGPG SLSPHSKPPS
850 860 870
PSLCSETEDL DQDLSVKKFP YQPLPQAPAI QFFKSLKY